Announcements Trials
Browse Landscape

Status

Completed 5Unknown 1

Sponsor Class

NETWORK 3NIH 2FED 1

Study Type

Observational 6Interventional 4

Sponsor

Cancer Type

Genitourinary 6

Conditions

Breast Neoplasms 20Leukemia 11Lymphoma 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 6Lymphoma, Follicular 6Ovarian Neoplasms 5Neuroblastoma 5Kidney Neoplasms 5Carcinoma, Ovarian Epithelial 5Wilms Tumor 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Colonic Neoplasms 4Central Nervous System Neoplasms 4Adenocarcinoma of Lung 4Testicular Neoplasms 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Surveys and Questionnaires 34Blood Specimen Collection 24enzalutamide 18Radiotherapy 15Docetaxel 15Biopsy 14Abiraterone Acetate 14apalutamide 13Leuprolide 13Interviews as Topic 13Observation 12Magnetic Resonance Spectroscopy 12Watchful Waiting 10radium Ra 223 dichloride 9darolutamide 9Androgen Antagonists 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Radiosurgery 7Magnetic Resonance Imaging 7Brachytherapy 7abiraterone 6Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6Triptorelin Pamoate 5Standard of Care 5Positron Emission Tomography Computed Tomography 5Gonadotropin-Releasing Hormone 5Focus Groups 5Registries 4Radiotherapy, Intensity-Modulated 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Prostatic Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01013129 2021-11-11

Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer

Portland VA Medical Center

Completed
748 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms

NCT00899184 2017-05-19

DNA Changes in Patients With Prostate Cancer

Eastern Cooperative Oncology Group

Completed
646 enrolled
Genitourinary

Prostatic Neoplasms

NCT00897351 2017-05-17

Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803

Eastern Cooperative Oncology Group

Completed
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT01120262 2016-10-07

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

SWOG Cancer Research Network

Completed
545 enrolled
Genitourinary

Prostatic Neoplasms

NCT00900185 2015-04-30

Study of a Polymorphism in Patients With Prostate Cancer

National Cancer Institute (NCI)

Completed
750 enrolled
Genitourinary

Prostatic Neoplasms

NCT00758173 2013-08-26

Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom

National Cancer Institute (NCI)

Unknown
2,000 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡